Table S1 from Oxidative Phosphorylation Fueled by Fatty Acid Oxidation Sensitizes Leukemic Stem Cells to Cold

Table S1 from Oxidative Phosphorylation Fueled by Fatty Acid Oxidation Sensitizes Leukemic Stem Cells to Cold

<p>AML_Patient_Clinical features</p>

Guardat en:

Dades bibliogràfiques
Autor principal:	Emmanuel Griessinger (16721087) (author)
Altres autors:	Diego Pereira-Martins (16721090) (author), Marielle Nebout (16721093) (author), Claudie Bosc (16721096) (author), Estelle Saland (16446003) (author), Emiline Boet (16721099) (author), Ambrine Sahal (16446000) (author), Johanna Chiche (16721102) (author), Delphine Debayle (16721105) (author), Lucile Fleuriot (16721108) (author), Maurien Pruis (16721111) (author), Véronique De Mas (16721114) (author), François Vergez (15047358) (author), Christian Récher (15047355) (author), Gerwin Huls (16721117) (author), Jean-Emmanuel Sarry (15112165) (author), Jan Jacob Schuringa (16721120) (author), Jean-François Peyron (16721123) (author)
Publicat:	2025
Matèries:	Cancer Molecular and Cellular Biology Cancer Detection and Diagnosis Biomarkers Hematological Cancers Leukemias Metabolism Mitochondrial function Proteomics Stem Cell Biology Cancer stem cells
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars

Table S2 from Oxidative Phosphorylation Fueled by Fatty Acid Oxidation Sensitizes Leukemic Stem Cells to Cold
per: Emmanuel Griessinger (16721087)
Publicat: (2025)

Supplementary Table S1 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
per: Ana Vujovic (15207479)
Publicat: (2025)

Supplementary Table S2 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
per: Ana Vujovic (15207479)
Publicat: (2025)

Supplementary Table S3 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
per: Ana Vujovic (15207479)
Publicat: (2025)

Supplementary Table S4 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
per: Ana Vujovic (15207479)
Publicat: (2025)

Supplementary Table S5 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
per: Ana Vujovic (15207479)
Publicat: (2025)

Supplementary Table S6 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
per: Ana Vujovic (15207479)
Publicat: (2025)

Supplementary Table S7 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
per: Ana Vujovic (15207479)
Publicat: (2025)

Supplementary Table S8 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
per: Ana Vujovic (15207479)
Publicat: (2025)

Supplementary Table S9 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
per: Ana Vujovic (15207479)
Publicat: (2025)

Source Data from Ablation of p57<sup>+</sup> Quiescent Cancer Stem Cells Suppresses Recurrence after Chemotherapy of Intestinal Tumors
per: Takeru Oka (15386810)
Publicat: (2025)

Supplementary Table S1 from Ablation of p57<sup>+</sup> Quiescent Cancer Stem Cells Suppresses Recurrence after Chemotherapy of Intestinal Tumors
per: Takeru Oka (15386810)
Publicat: (2025)

Graphical abstract from Single-Cell Spatial Analysis Identifies Regulators of Brain Tumor–Initiating Cells
per: Reza Mirzaei (15306062)
Publicat: (2025)

Supplementary Table S1 from Single-Cell Spatial Analysis Identifies Regulators of Brain Tumor–Initiating Cells
per: Reza Mirzaei (15306062)
Publicat: (2025)

Supplementary Table S2 from Single-Cell Spatial Analysis Identifies Regulators of Brain Tumor–Initiating Cells
per: Reza Mirzaei (15306062)
Publicat: (2025)

Anexos. Diagnóstico de la capacitación docente para la implementación del enfoque STEM en educación primaria
per: Nadia Lucero Pérez Baez (22684485)
Publicat: (2025)

Table 2_How artificial intelligence can enable personalized mesenchymal stem cell–based therapeutic strategies in systemic lupus erythematosus.docx
per: Sushmitha Rajeev Kumar (22687190)
Publicat: (2025)

Table 1_How artificial intelligence can enable personalized mesenchymal stem cell–based therapeutic strategies in systemic lupus erythematosus.docx
per: Sushmitha Rajeev Kumar (22687190)
Publicat: (2025)

Quantitative Proteomics Links Mitochondrial Dysfunction to Metabolic Changes and Epithelial Differentiation Defects in Hyperoxia-Exposed Neonatal Airway Cells
per: Abhrajit Ganguly (21540245)
Publicat: (2025)

Table S1 from A Single-Cell Taxonomy Predicts Inflammatory Niche Remodeling to Drive Tissue Failure and Outcome in Human AML
per: Lanpeng Chen (16918293)
Publicat: (2025)

Table S2 from A Single-Cell Taxonomy Predicts Inflammatory Niche Remodeling to Drive Tissue Failure and Outcome in Human AML
per: Lanpeng Chen (16918293)
Publicat: (2025)

Table S3 from A Single-Cell Taxonomy Predicts Inflammatory Niche Remodeling to Drive Tissue Failure and Outcome in Human AML
per: Lanpeng Chen (16918293)
Publicat: (2025)

Table S4 from A Single-Cell Taxonomy Predicts Inflammatory Niche Remodeling to Drive Tissue Failure and Outcome in Human AML
per: Lanpeng Chen (16918293)
Publicat: (2025)

Table S5 from A Single-Cell Taxonomy Predicts Inflammatory Niche Remodeling to Drive Tissue Failure and Outcome in Human AML
per: Lanpeng Chen (16918293)
Publicat: (2025)

Table S6 from A Single-Cell Taxonomy Predicts Inflammatory Niche Remodeling to Drive Tissue Failure and Outcome in Human AML
per: Lanpeng Chen (16918293)
Publicat: (2025)

Table S7 from A Single-Cell Taxonomy Predicts Inflammatory Niche Remodeling to Drive Tissue Failure and Outcome in Human AML
per: Lanpeng Chen (16918293)
Publicat: (2025)

Data Sheet 1_MRI-based radiomic clustering identifies a glioblastoma subtype enriched for neural stemness and proliferative programs.csv
per: Zhongyi Zhang (219440)
Publicat: (2025)

Data Sheet 2_MRI-based radiomic clustering identifies a glioblastoma subtype enriched for neural stemness and proliferative programs.pdf
per: Zhongyi Zhang (219440)
Publicat: (2025)

Investigation on the Occurrence of Premature Ovarian Insufficiency after Allogeneic Haematopoietic Stem Cell Transplantation and Prognosis Analysis - a single-center real-world cross-sectional study
per: 辰宇石 (22420348)
Publicat: (2025)

Video 2_Doxorubicin induces cardiotoxicity by enhancing autophagy via mTOR signaling in hiPSC- and hESC-derived cardiomyocytes.mp4
per: Minxia Ke (4889887)
Publicat: (2025)

Data Sheet 1_Doxorubicin induces cardiotoxicity by enhancing autophagy via mTOR signaling in hiPSC- and hESC-derived cardiomyocytes.docx
per: Minxia Ke (4889887)
Publicat: (2025)

Video 1_Doxorubicin induces cardiotoxicity by enhancing autophagy via mTOR signaling in hiPSC- and hESC-derived cardiomyocytes.mp4
per: Minxia Ke (4889887)
Publicat: (2025)

Figure 1 from Exploiting Natural Killer Cell Engagers to Control Pediatric B-cell Precursor Acute Lymphoblastic Leukemia
per: Natalia Colomar-Carando (14611340)
Publicat: (2025)

Figure 2 from Exploiting Natural Killer Cell Engagers to Control Pediatric B-cell Precursor Acute Lymphoblastic Leukemia
per: Natalia Colomar-Carando (14611340)
Publicat: (2025)

Figure 3 from Exploiting Natural Killer Cell Engagers to Control Pediatric B-cell Precursor Acute Lymphoblastic Leukemia
per: Natalia Colomar-Carando (14611340)
Publicat: (2025)

Figure 4 from Exploiting Natural Killer Cell Engagers to Control Pediatric B-cell Precursor Acute Lymphoblastic Leukemia
per: Natalia Colomar-Carando (14611340)
Publicat: (2025)

Figure 5 from Exploiting Natural Killer Cell Engagers to Control Pediatric B-cell Precursor Acute Lymphoblastic Leukemia
per: Natalia Colomar-Carando (14611340)
Publicat: (2025)

Supplementary Data from ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma
per: Evangeline R. Jackson (15558808)
Publicat: (2025)

Supplementary file 1_Drug combination discovery assisted by AI and untargeted metabolomics: pamiparib and anlotinib synergistic potentiation for ovarian cancer treatment.docx
per: Dong Wang (73290)
Publicat: (2025)

Table S1-S3 from Clonal Hematopoiesis Mutations in Patients with Lung Cancer Are Associated with Lung Cancer Risk Factors
per: Wei Hong (432102)
Publicat: (2025)

Cannot write session to /tmp/vufind_sessions/sess_3qp19bpcsrejgcekh12ie35amf